$CVTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CV THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CV THERAPEUTICS INC. Get notifications about new insider transactions in CV THERAPEUTICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 17 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Option Exercise | M | 10.45 | 88,542 | 925,264 | 0 | |
Apr 17 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Option Exercise | M | 10.45 | 88,542 | 925,264 | 0 | |
Apr 17 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Option Exercise | M | 10.45 | 354,167 | 3,701,045 | 0 | |
Apr 16 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Option Exercise | M | 8.74 | 2,500 | 21,850 | 0 | |
Apr 16 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Option Exercise | M | 8.74 | 3,750 | 32,775 | 0 | |
Apr 16 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Option Exercise | M | 8.74 | 2,500 | 21,850 | 0 | |
Apr 16 2009 | CVTX | CV THERAPEUTICS IN ... | DAVIE JOSEPH MD PHD | Director | Option Exercise | M | 8.74 | 2,500 | 21,850 | 0 | |
Apr 16 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Option Exercise | M | 8.74 | 2,500 | 21,850 | 0 | |
Apr 16 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Option Exercise | M | 13.33 | 15,000 | 199,950 | 0 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Payment of Exercise | F | 19.94 | 5,950 | 118,643 | 67,489 | 73.4 K to 67.5 K (-8.10 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Payment of Exercise | F | 19.94 | 20,278 | 404,343 | 483,618 | 503.9 K to 483.6 K (-4.02 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Option Exercise | M | 13.33 | 8,100 | 107,973 | 0 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Option Exercise | M | 13.38 | 10,000 | 133,800 | 0 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Option Exercise | M | 10.45 | 98,958 | 1,034,111 | 88,542 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Payment of Exercise | F | 19.94 | 6,457 | 128,753 | 57,774 | 64.2 K to 57.8 K (-10.05 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Buy | M | 13.33 | 8,100 | 107,973 | 64,231 | 56.1 K to 64.2 K (+14.43 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Payment of Exercise | F | 19.94 | 7,988 | 159,281 | 56,131 | 64.1 K to 56.1 K (-12.46 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Buy | M | 13.38 | 10,000 | 133,800 | 64,119 | 54.1 K to 64.1 K (+18.48 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Payment of Exercise | F | 19.94 | 69,569 | 1,387,206 | 54,119 | 123.7 K to 54.1 K (-56.25 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Buy | M | 10.45 | 98,958 | 1,034,111 | 123,688 | 24.7 K to 123.7 K (+400.15 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Option Exercise | M | 19.91 | 7,500 | 149,325 | 0 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Option Exercise | M | 17.03 | 7,500 | 127,725 | 0 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Option Exercise | M | 8.74 | 12,500 | 109,250 | 2,500 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Option Exercise | M | 10.45 | 7,500 | 78,375 | 0 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Option Exercise | M | 12.91 | 7,500 | 96,825 | 0 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Option Exercise | M | 15.60 | 7,500 | 117,000 | 0 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Payment of Exercise | F | 19.94 | 7,500 | 149,550 | 14,152 | 21.7 K to 14.2 K (-34.64 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Buy | M | 19.91 | 7,500 | 149,325 | 21,652 | 14.2 K to 21.7 K (+53.00 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Payment of Exercise | F | 19.94 | 6,931 | 138,204 | 14,152 | 21.1 K to 14.2 K (-32.87 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Buy | M | 17.03 | 7,500 | 127,725 | 21,083 | 13.6 K to 21.1 K (+55.22 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Payment of Exercise | F | 19.94 | 8,394 | 167,376 | 13,583 | 22 K to 13.6 K (-38.19 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Buy | M | 8.74 | 12,500 | 109,250 | 21,977 | 9.5 K to 22 K (+131.90 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Payment of Exercise | F | 19.94 | 5,428 | 108,234 | 9,477 | 14.9 K to 9.5 K (-36.42 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Buy | M | 10.45 | 7,500 | 78,375 | 14,905 | 7.4 K to 14.9 K (+101.28 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Payment of Exercise | F | 19.94 | 5,990 | 119,441 | 7,405 | 13.4 K to 7.4 K (-44.72 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Buy | M | 12.91 | 7,500 | 96,825 | 13,395 | 5.9 K to 13.4 K (+127.23 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Payment of Exercise | F | 19.94 | 6,605 | 131,704 | 5,895 | 12.5 K to 5.9 K (-52.84 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | GUTSHALL THOMAS L | Director | Buy | M | 15.60 | 7,500 | 117,000 | 12,500 | 5 K to 12.5 K (+150.00 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Option Exercise | M | 19.91 | 7,500 | 149,325 | 0 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Option Exercise | M | 8.74 | 12,500 | 109,250 | 2,500 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Option Exercise | M | 10.45 | 7,500 | 78,375 | 0 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Option Exercise | M | 15.60 | 7,500 | 117,000 | 0 | |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Payment of Exercise | F | 19.94 | 7,500 | 149,550 | 8,073 | 15.6 K to 8.1 K (-48.16 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Buy | M | 19.91 | 7,500 | 149,325 | 15,573 | 8.1 K to 15.6 K (+92.90 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Payment of Exercise | F | 19.94 | 8,394 | 167,376 | 8,073 | 16.5 K to 8.1 K (-50.97 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Sell | M | 8.74 | 12,500 | 109,250 | 16,467 | 29 K to 16.5 K (-43.15 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Payment of Exercise | F | 19.94 | 5,428 | 108,234 | 3,967 | 9.4 K to 4 K (-57.78 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Sell | M | 10.45 | 7,500 | 78,375 | 9,395 | 16.9 K to 9.4 K (-44.39 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Payment of Exercise | F | 19.94 | 6,605 | 131,704 | 1,895 | 8.5 K to 1.9 K (-77.71 %) |
Apr 09 2009 | CVTX | CV THERAPEUTICS IN ... | SHENK THOMAS E | Director | Sell | M | 15.60 | 7,500 | 117,000 | 8,500 | 16 K to 8.5 K (-46.87 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Option Exercise | M | 8.74 | 12,500 | 109,250 | 2,500 | |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Option Exercise | M | 10.45 | 7,500 | 78,375 | 0 | |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Option Exercise | M | 17.03 | 7,500 | 127,725 | 0 | |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Option Exercise | M | 15.60 | 7,500 | 117,000 | 0 | |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Option Exercise | M | 19.91 | 7,500 | 149,325 | 0 | |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Option Exercise | M | 12.91 | 7,500 | 96,825 | 0 | |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Payment of Exercise | F | 19.93 | 8,395 | 167,312 | 9,146 | 17.5 K to 9.1 K (-47.86 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Buy | M | 8.74 | 12,500 | 109,250 | 17,541 | 5 K to 17.5 K (+247.97 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Payment of Exercise | F | 19.93 | 5,429 | 108,200 | 5,041 | 10.5 K to 5 K (-51.85 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Buy | M | 10.45 | 7,500 | 78,375 | 10,470 | 3 K to 10.5 K (+252.53 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Payment of Exercise | F | 19.93 | 6,933 | 138,175 | 2,970 | 9.9 K to 3 K (-70.01 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Buy | M | 17.03 | 7,500 | 127,725 | 9,093 | 1.6 K to 9.1 K (+470.81 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Payment of Exercise | F | 19.93 | 6,606 | 131,658 | 2,403 | 9 K to 2.4 K (-73.33 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Buy | M | 15.60 | 7,500 | 117,000 | 9,009 | 1.5 K to 9 K (+497.02 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Payment of Exercise | F | 19.93 | 7,500 | 149,475 | 1,509 | 9 K to 1.5 K (-83.25 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Buy | M | 19.91 | 7,500 | 149,325 | 9,009 | 1.5 K to 9 K (+497.02 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Payment of Exercise | F | 19.93 | 5,991 | 119,401 | 1,509 | 7.5 K to 1.5 K (-79.88 %) |
Apr 06 2009 | CVTX | CV THERAPEUTICS IN ... | COSTA SANTO J | Director | Buy | M | 12.91 | 7,500 | 96,825 | 7,500 | 0 to 7.5 K |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Option Exercise | M | 8.74 | 18,750 | 163,875 | 3,750 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Option Exercise | M | 10.45 | 7,500 | 78,375 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Option Exercise | M | 15.60 | 7,500 | 117,000 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Option Exercise | M | 19.91 | 7,500 | 149,325 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Option Exercise | M | 12.91 | 7,500 | 96,825 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Option Exercise | M | 17.03 | 7,500 | 127,725 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Payment of Exercise | F | 19.92 | 12,595 | 250,892 | 11,670 | 24.3 K to 11.7 K (-51.91 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Buy | M | 8.74 | 18,750 | 163,875 | 24,265 | 5.5 K to 24.3 K (+339.98 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Payment of Exercise | F | 19.92 | 5,430 | 108,166 | 5,515 | 10.9 K to 5.5 K (-49.61 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Buy | M | 10.45 | 7,500 | 78,375 | 10,945 | 3.4 K to 10.9 K (+217.71 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Payment of Exercise | F | 19.92 | 6,702 | 133,504 | 3,445 | 10.1 K to 3.4 K (-66.05 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Buy | M | 15.60 | 7,500 | 117,000 | 10,147 | 2.6 K to 10.1 K (+283.34 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Payment of Exercise | F | 19.92 | 7,500 | 149,400 | 2,647 | 10.1 K to 2.6 K (-73.91 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Buy | M | 19.91 | 7,500 | 149,325 | 10,147 | 2.6 K to 10.1 K (+283.34 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Payment of Exercise | F | 19.92 | 5,993 | 119,381 | 2,647 | 8.6 K to 2.6 K (-69.36 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Buy | M | 12.91 | 7,500 | 96,825 | 8,640 | 1.1 K to 8.6 K (+657.89 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Payment of Exercise | F | 19.92 | 6,935 | 138,145 | 1,140 | 8.1 K to 1.1 K (-85.88 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LEE KENNETH B JR | Director | Buy | M | 17.03 | 7,500 | 127,725 | 8,075 | 575 to 8.1 K (+1,304.35 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | DAVIE JOSEPH MD PHD | Director | Option Exercise | M | 8.74 | 12,500 | 109,250 | 2,500 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | DAVIE JOSEPH MD PHD | Director | Option Exercise | M | 10.45 | 7,500 | 78,375 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | DAVIE JOSEPH MD PHD | Director | Option Exercise | M | 15.60 | 7,500 | 117,000 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | DAVIE JOSEPH MD PHD | Director | Payment of Exercise | F | 19.92 | 8,397 | 167,268 | 7,065 | 15.5 K to 7.1 K (-54.31 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | DAVIE JOSEPH MD PHD | Director | Buy | M | 8.74 | 12,500 | 109,250 | 15,462 | 3 K to 15.5 K (+422.01 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | DAVIE JOSEPH MD PHD | Director | Payment of Exercise | F | 19.92 | 5,430 | 108,166 | 2,962 | 8.4 K to 3 K (-64.70 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | DAVIE JOSEPH MD PHD | Director | Buy | M | 10.45 | 7,500 | 78,375 | 8,392 | 892 to 8.4 K (+840.81 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | DAVIE JOSEPH MD PHD | Director | Payment of Exercise | F | 19.92 | 6,608 | 131,631 | 892 | 7.5 K to 892 (-88.11 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | DAVIE JOSEPH MD PHD | Director | Buy | M | 15.60 | 7,500 | 117,000 | 7,500 | 0 to 7.5 K |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Option Exercise | M | 10.45 | 98,958 | 1,034,111 | 88,542 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Option Exercise | M | 13.33 | 15,000 | 199,950 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Option Exercise | M | 13.16 | 50,000 | 658,000 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Payment of Exercise | F | 19.91 | 69,620 | 1,386,134 | 57,375 | 127 K to 57.4 K (-54.82 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Buy | M | 10.45 | 98,958 | 1,034,111 | 126,995 | 28 K to 127 K (+352.96 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Payment of Exercise | F | 19.91 | 11,966 | 238,243 | 28,037 | 40 K to 28 K (-29.91 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Buy | M | 13.33 | 15,000 | 199,950 | 40,003 | 25 K to 40 K (+59.99 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Payment of Exercise | F | 19.91 | 39,605 | 788,536 | 25,003 | 64.6 K to 25 K (-61.30 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Buy | M | 13.16 | 50,000 | 658,000 | 64,608 | 14.6 K to 64.6 K (+342.28 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Option Exercise | M | 17.03 | 25,000 | 425,750 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Option Exercise | M | 10.45 | 98,958 | 1,034,111 | 88,542 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Option Exercise | M | 13.33 | 15,000 | 199,950 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Option Exercise | M | 13.16 | 75,000 | 987,000 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Payment of Exercise | F | 19.91 | 22,965 | 457,233 | 87,743 | 110.7 K to 87.7 K (-20.74 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Buy | M | 17.03 | 25,000 | 425,750 | 110,708 | 85.7 K to 110.7 K (+29.17 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Payment of Exercise | F | 19.91 | 69,620 | 1,386,134 | 85,708 | 155.3 K to 85.7 K (-44.82 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Buy | M | 10.45 | 98,958 | 1,034,111 | 155,328 | 56.4 K to 155.3 K (+175.55 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Payment of Exercise | F | 19.91 | 11,966 | 238,243 | 56,370 | 68.3 K to 56.4 K (-17.51 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Buy | M | 13.33 | 15,000 | 199,950 | 68,336 | 53.3 K to 68.3 K (+28.12 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Payment of Exercise | F | 19.91 | 59,407 | 1,182,793 | 53,336 | 112.7 K to 53.3 K (-52.69 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | BLACKBURN BRENT K | SVP, Drug Discovery ... | Buy | M | 13.16 | 75,000 | 987,000 | 112,743 | 37.7 K to 112.7 K (+198.71 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Option Exercise | M | 10.45 | 98,958 | 1,034,111 | 88,542 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Option Exercise | M | 13.33 | 15,000 | 199,950 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Option Exercise | M | 13.16 | 75,000 | 987,000 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Sell | S | 19.91 | 69,637 | 1,386,473 | 73,439 | 143.1 K to 73.4 K (-48.67 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Buy | M | 10.45 | 98,958 | 1,034,111 | 143,076 | 44.1 K to 143.1 K (+224.30 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Sell | S | 19.91 | 11,969 | 238,303 | 44,118 | 56.1 K to 44.1 K (-21.34 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Buy | M | 13.33 | 15,000 | 199,950 | 56,087 | 41.1 K to 56.1 K (+36.51 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Sell | S | 19.91 | 59,423 | 1,183,112 | 41,087 | 100.5 K to 41.1 K (-59.12 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Buy | M | 13.16 | 75,000 | 987,000 | 100,510 | 25.5 K to 100.5 K (+294.00 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Option Exercise | M | 10.45 | 395,833 | 4,136,455 | 354,167 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Option Exercise | M | 13.33 | 20,250 | 269,933 | 15,750 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Option Exercise | M | 17.03 | 50,000 | 851,500 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Option Exercise | M | 13.16 | 175,000 | 2,303,000 | 0 | |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Sell | S | 19.90 | 278,477 | 5,541,692 | 503,896 | 782.4 K to 503.9 K (-35.59 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Buy | M | 10.45 | 395,833 | 4,136,455 | 782,373 | 386.5 K to 782.4 K (+102.40 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Sell | S | 19.90 | 16,154 | 321,465 | 386,540 | 402.7 K to 386.5 K (-4.01 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Buy | M | 19.90 | 20,250 | 402,975 | 402,694 | 382.4 K to 402.7 K (+5.29 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Sell | S | 19.90 | 45,929 | 913,987 | 382,444 | 428.4 K to 382.4 K (-10.72 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Buy | M | 17.03 | 50,000 | 851,500 | 428,373 | 378.4 K to 428.4 K (+13.21 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Sell | S | 19.90 | 138,615 | 2,758,439 | 378,373 | 517 K to 378.4 K (-26.81 %) |
Apr 03 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Buy | M | 13.16 | 175,000 | 2,303,000 | 516,988 | 342 K to 517 K (+51.17 %) |
Mar 26 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Option Exercise | M | 0.00 | 1,293 | 0 | 12,934 | |
Mar 26 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Option Exercise | M | 0.00 | 10,052 | 0 | 100,519 | |
Mar 26 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Payment of Exercise | F | 19.88 | 572 | 11,371 | 341,988 | 342.6 K to 342 K (-0.17 %) |
Mar 26 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Buy | M | 19.88 | 1,293 | 25,705 | 342,560 | 341.3 K to 342.6 K (+0.38 %) |
Mar 26 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Payment of Exercise | F | 19.88 | 4,453 | 88,526 | 341,267 | 345.7 K to 341.3 K (-1.29 %) |
Mar 26 2009 | CVTX | CV THERAPEUTICS IN ... | LANGE LOUIS G | Chairman & CEO | Buy | M | 19.88 | 10,052 | 199,834 | 345,720 | 335.7 K to 345.7 K (+2.99 %) |
Feb 26 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Option Exercise | M | 0.00 | 12,499 | 0 | 45,313 | |
Feb 26 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Payment of Exercise | F | 15.58 | 4,317 | 67,259 | 24,730 | 29 K to 24.7 K (-14.86 %) |
Feb 26 2009 | CVTX | CV THERAPEUTICS IN ... | STUART LEWIS J | SVP COMMERCIAL OPER ... | Buy | M | 15.58 | 12,499 | 194,734 | 27,605 | 15.1 K to 27.6 K (+82.74 %) |
Feb 26 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Option Exercise | M | 0.00 | 12,499 | 0 | 45,313 | |
Feb 26 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Payment of Exercise | F | 15.58 | 4,317 | 67,259 | 14,608 | 18.9 K to 14.6 K (-22.81 %) |
Feb 26 2009 | CVTX | CV THERAPEUTICS IN ... | SUVARI TRICIA BORGA | SVP, General Counse ... | Buy | M | 15.58 | 12,499 | 194,734 | 18,925 | 6.4 K to 18.9 K (+194.51 %) |
Feb 26 2009 | CVTX | CV THERAPEUTICS IN ... | SPIEGELMAN DANIEL K | SVP, CFO | Option Exercise | M | 0.00 | 12,499 | 0 | 45,313 |